Participants in Medicine Grand Rounds will be able to identify and apply the most current treatment guidelines and standards of practice to provide optimal patient care, incorporating the principles of evidence-based medicine and innovative strategies to achieve clinical quality and safety goals.
Presenter
Charles D. Brackett, MD, MPH, FACP, FASAM
Associate Professor of Medicine and Health Policy Clinical Practice
Geisel School of Medicine at Dartmouth and The Dartmouth Institute
General Internal Medicine and Population Health
About our Presenter
Dr. Charles Brackett is a primary care internist at DHMC who divides his time between seeing patients, teaching residents, and working in Population Health. He is the Primary Care Lead for behavioral health integration and the Director of the Opioid Addiction Treatment Collaborative at Dartmouth Health.
Dr. Brackett is a graduate of Yale University School of Medicine and earned his MPH at the Boston University School of Public Health. He completed his internal medicine residency at Cambridge Hospital in Massachusetts, fellowship in general internal medicine at Boston University, and a community medicine fellowship at Boston Medical Center. He is board certified in Internal Medicine and Addiction Medicine.
Learning Outcome(s)
Participants will be able to review optimal management of chronic pain while discussing different subtypes of pain, and appreciating the potential harms of long-term opioid therapy, especially when harms exceed benefits.
Disclosure
The following activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported the following financial relationship(s)* with ineligible company(ies)**. All of the relevant financial relationships listed for these individuals have been mitigated.
Richard Rothstein, MD ~ has a research grant from Fractyl, and is a consultant/advisor and has stock ownership with Allurion.
* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Bibliographic Material
See the presentation for additional bibliographic resources.
